Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 10 October 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages indicate a mildly bullish stance. The Bollinger Bands also reflect a mildly bullish trend in both weekly and monthly time frames. However, the KST is mildly bearish on both weekly and monthly charts, and the Dow Theory shows no trend on the weekly but is mildly bullish monthly. The OBV is bullish monthly but mildly bullish weekly.
In terms of performance, Neurocrine has underperformed the S&P 500 in the short term, with a -3.27% return over the past month compared to a 0.31% gain for the index. However, it has outperformed the S&P 500 over the past year with a 21.55% return versus 13.36%. Overall, the current technical stance is mildly bullish, driven primarily by the MACD and moving averages, despite some bearish signals from KST.